Compare PRPO & MVIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRPO | MVIS |
|---|---|---|
| Founded | N/A | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Industrial Machinery/Components |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.3M | 45.0M |
| IPO Year | 2000 | 2010 |
| Metric | PRPO | MVIS |
|---|---|---|
| Price | $18.95 | $1.17 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 33.1K | ★ 1.3M |
| Earning Date | 11-10-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 92.15 | 23.91 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $24,049,000.00 | $664,000.00 |
| Revenue This Year | $233.72 | $1,017.55 |
| Revenue Next Year | $22.61 | $48.15 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 29.77 | N/A |
| 52 Week Low | $17.79 | $0.23 |
| 52 Week High | $33.63 | $4.90 |
| Indicator | PRPO | MVIS |
|---|---|---|
| Relative Strength Index (RSI) | 38.17 | 40.54 |
| Support Level | N/A | $1.08 |
| Resistance Level | $24.78 | $1.52 |
| Average True Range (ATR) | 1.09 | 0.12 |
| MACD | 0.05 | 0.01 |
| Stochastic Oscillator | 24.44 | 11.14 |
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
Microvision Inc is engaged in developing a lidar sensor to be used in automotive safety and autonomous driving applications. Its lidar sensor uses laser beam scanning (LBS) technology, which is based on systems that include micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company has also developed solutions for Augmented Reality, Interactive Displays, and Consumer Lidars. Geographically, the company operates in United States, Germany, and Other foreign countries.